Suppression of cancer cachexia by 20S,21-epoxy-resibufogenin-3-acetate-a novel nonpeptide IL-6 receptor antagonist

Biochemical and Biophysical Research Communications
Akiko EnomotoMasahiko Hayashi

Abstract

While screening for novel IL-6 inhibitors, we synthesized 20S,21-epoxy-resibufogenin-3-acetate (ERBA). ERBA dose-dependently suppressed IL-6-induced cell growth with an IC(50) value of 5.3 microM and caused a parallel rightward shift of dose-response curves to IL-6. Analysis of data yields a pA2 of 5.83 and a slope of 0.99. ERBA did not affect IL-2-, IL-3-, and GCSF-dependent cell growth, or tumor necrosis factor alpha-induced growth suppression, nor did ERBA affect osteoclast formation induced by IL-11, leukemia inhibitory factor, and 1alpha,25-dihydroxyvitamin D(3). Receptor assay showed that ERBA dose-dependently suppressed IL-6 binding to IL-6 receptor (IL-6R). Furthermore, no band existing at the position of IL-6R in Western blots of ERBA-treated cells when stimulated with IL-6:ERBA suppresses IL-6 activity by blocking the binding of IL-6 to IL-6R. In an experimental model of colon 26-induced cancer cachexia, ERBA markedly inhibited body weight loss. ERBA is a specific small molecule with IL-6R-antagonist activity.

References

Aug 1, 1992·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Y HiraiM Sakanashi
Sep 1, 1994·Leukemia & Lymphoma·S KobayashiH Mizoguchi
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T TamuraT Taga
Apr 15, 1993·Biochemical and Biophysical Research Communications·T OhmoriT Ohira
Jan 1, 1989·International Reviews of Immunology·T MatsudaT Kishimoto
Sep 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Masahiko HayashiKanki Komiyama
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Masahiko HayashiSatoshi Omura
Dec 29, 2004·Journal of Natural Products·Akiko EnomotoMasahiko Hayashi
Nov 24, 2012·Current Clinical Pharmacology·Idalia SariegoLázara Rojas
Aug 30, 2014·Journal of Cachexia, Sarcopenia and Muscle·Míriam ToledoJosep M Argilés

❮ Previous
Next ❯

Citations

Sep 30, 2006·Cancer Chemotherapy and Pharmacology·Kaori Fujimoto-OuchiYutaka Tanaka
Apr 11, 2006·Annual Review of Nutrition·Vickie E Baracos
Oct 1, 2013·Pharmacology & Therapeutics·Xin YaoYihong Yao
Aug 10, 2007·Expert Opinion on Investigational Drugs·Maurizio BossolaGiovan Battista Doglietto
Jul 3, 2010·Expert Opinion on Biological Therapy·Fabio PennaPaola Costelli
Apr 27, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jules B PuschettMohammad N Uddin
Aug 18, 2005·The International Journal of Biochemistry & Cell Biology·Josep M ArgilésFrancisco J López-Soriano
Jul 27, 2005·Nutrition·Josep M ArgilésFrancisco J López-Soriano
May 10, 2005·The International Journal of Biochemistry & Cell Biology·Josep M ArgilésFrancisco J López-Soriano
Mar 19, 2014·Head & Neck·Marion E CouchHirak Der-Torossian
Jun 27, 2015·The Journal of Endocrinology·Maria Carolina S MendesJosé B C Carvalheira
Jan 5, 2007·JPEN. Journal of Parenteral and Enteral Nutrition·Yong-Jun NaiJie-Shou Li
Jun 29, 2006·Lab on a Chip·Cheuk-Wing LiMengsu Yang
Dec 12, 2019·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Helene Nissrine Daou
Aug 19, 2008·Biological Research for Nursing·Sadeeka Al-Majid, Haidee Waters
Sep 24, 2015·Physiological Genomics·Angie M Y ShumPatsie Polly
Sep 21, 2017·Molecular Cancer·Sarra Setrerrahmane, Hanmei Xu
Nov 5, 2016·Molecular Cancer Therapeutics·Erin E TalbertGregory B Lesinski
Oct 30, 2020·International Journal of Molecular Sciences·Jan BrábekKarel Smetana

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.